欧罗拉生物科技

海报展示

[vc_row el_class=”blue”][vc_column width=”1/3″][vc_wp_custommenu nav_menu=”66″]

[vc_column width=”2/3″]

ionChannelRetreatLogo2014

Poster Presentations

  • Stepana Boukalova – Ph.D. Student, Charles University – The role of alanine residues in the first transmembrane region of TRPV1 channel
  • Ben Butterfield – Executive Director of Business Development, North America, Cyprotex – Development of an in vitro Multiwell Cardiovascular Multielectrode Array (MEA) Toxicity Assay with Human IPS Derived Cardiomyocytes
  • Javier Camacho – Researcher, Ph.D., Department of Pharmacology, Centro de Investigación y de Estudios Avanzados (CINVESTAV) del Instituto Politécnico Nacional – Astemizole in the treatment and prevention of hepatocellular carcinoma (HCC) and Eag1 K channels as potential early markers of HCC
  • Wanjuan Chen [vc_row el_class=”blue”][vc_column width=”1/3″][vc_wp_custommenu nav_menu=”66″]

[vc_column width=”2/3″]

ionChannelRetreatLogo2014

Poster Presentations

  • Stepana Boukalova – Ph.D. Student, Charles University – The role of alanine residues in the first transmembrane region of TRPV1 channel
  • Ben Butterfield – Executive Director of Business Development, North America, Cyprotex – Development of an in vitro Multiwell Cardiovascular Multielectrode Array (MEA) Toxicity Assay with Human IPS Derived Cardiomyocytes
  • Javier Camacho – Researcher, Ph.D., Department of Pharmacology, Centro de Investigación y de Estudios Avanzados (CINVESTAV) del Instituto Politécnico Nacional – Astemizole in the treatment and prevention of hepatocellular carcinoma (HCC) and Eag1 K channels as potential early markers of HCC
  • Wanjuan Chen